Invited commentary: Preventing neural tube defects and more via food fortification?

American Journal of Epidemiology

Volumn 169, Issue 1, 2009, Pages 18-21

  Mills, James L ^a   Carter, Tonia C ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Anencephaly; Folic acid; Food, fortified; Neural tube defects; Spinal dysraphism

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; METHAMPHETAMINE;

CARDIOVASCULAR DISEASE; CONCEPTION; FOLLOW UP; FOOD; FOOD INTAKE; GOVERNMENT; GROWTH; HEALTH CARE SYSTEM; HUMAN; LONG TERM CARE; NEOPLASM; NEURAL TUBE DEFECT; NOTE; PREGNANCY; PRIMARY PREVENTION; PUBLIC HEALTH; SCHOOL; UNITED STATES; VITAMIN SUPPLEMENTATION;

CONFIDENCE INTERVALS; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HOMOCYSTEINE; HUMANS; MARYLAND; MOTHERS; NEURAL TUBE DEFECTS; PREGNANCY; PRENATAL CARE; UNITED STATES; VITAMIN B COMPLEX;

EID: 58149240077     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn329     Document Type: Note

References (43)

1. US Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final rule. Fed Regist. 1996;61(44):8781-8797.
2. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet. 1991;338(8760):131-137.
3. Mulinare J, Cordero JF, Erickson JD, et al. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA. 1988;260(21):3141-3145.
4. Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA. 1989;262(20):2847-2852.
5. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA. 1993;269(10):1257-1261.
6. Shaw GM, Schaffer D, Velie EM, et al. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology. 1995;6(3):219-226.
7. Stevenson RE, Allen WP, Pai GS, et al. Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics. 2000;106(4):677-683.
8. Honein MA, Paulozzi LJ, Mathews TJ, et al. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 2001;285(23):2981-2986.
9. Spina bifida and anencephaly before and after folic acid mandate - United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep. 2004;53(17):362-365.
10. Simmons CJ, Mosley BS, Fulton-Bond CA, et al. Birth defects in Arkansas: Is folic acid fortification making a difference? Birth Defects Res A Clin Mol Teratol. 2004;70(9):559-564.
11. Part II. Regulatory impact analysis statement, SOR/98-550. Canada Gazette. 1998;132(24):3029-3033.
12. Ray JG, Meier C, Vermeulen MJ, et al. Association of neural tube defects and folic acid food fortification in Canada. Lancet. 2002;360(9350):2047- 2048.
13. Persad VL, Van den Hof MC, Dubé JM, et al. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ. 2002;167(3):241-245.
14. De Wals P, Rusen ID, Lee NS, et al. Trend in prevalence of neural tube defects in Quebec. Birth Defects Res A Clin Mol Teratol. 2003;67(11):919-923.
15. Liu S, West R, Randell E, et al. A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects [electronic article]. BMC Pregnancy Childbirth. 2004;4(1):20.
16. De Wals P, Tairou F, Van Allen MI, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007;357(2):135-142.
17. Mills JL, Signore C. Neural tube defect rates before and after food fortification with folic acid. Birth Defects Res A Clin Mol Teratol. 2004;70(11):844-845.
18. US Food and Drug Administration. Food standards: food labeling: health claims and label statements; folate and neural tube defects. Proposed rule. Fed Regist. 1993;58:53254-53295.
19. Rader JI, Weaver CM, Angyal G. Total folate in enriched cereal-grain products in the United States following fortification. Food Chem. 2000;70(3):275-289.
20. Daly LE, Kirke PN, Molloy A, et al. Folate levels and neural tube defects. Implications for prevention. JAMA. 1995;274(21):1698-1702.
21. Daly S, Mills JL, Molloy AM, et al. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet. 1997;350(9092):1666-1669.
22. Mosley BS, Cleves MA, Siega-Riz AM, et al. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol. 2008;169(1):9-17.
23. Bazzano LA, Reynolds K, Holder KN, et al. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA. 2006;296(22):2720-2726.
24. Spence JD. Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol. 2007;6(9):830-838.
25. Albert CM, Cook NR, Gaziano JM, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008;299(17):2027-2036.
26. B-Vitamin Treatment Trialists' Collaboration. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J. 2006;151(2):282-287.
27. Larsson SC, Giovannucci E, Wolk A. A prospective study of dietary folate intake and risk of colorectal cancer: modification by caffeine intake and cigarette smoking. Cancer Epidemiol Biomarkers Prev. 2005;14(3):740-743.
28. Schabath MB, Spitz MR, Lerner SP, et al. Case-control analysis of dietary folate and risk of bladder cancer. Nutr Cancer. 2005;53(2):144-151.
29. Murtaugh MA, Curtin K, Sweeney C, et al. Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer. Cancer Causes Control. 2007;18(2):153-163.
30. Ericson U, Sonestedt E, Gullberg B, et al. High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmö Diet and Cancer Cohort. Am J Clin Nutr. 2007;86(2):434-443.
31. Koutros S, Zhang Y, Zhu Y, et al. Nutrients contributing to one-carbon metabolism and risk of non-Hodgkin lymphoma subtypes. Am J Epidemiol. 2008;167(3):287-294.
32. Wagner C. Biochemical role of folate in cellular metabolism. In: Bailey LB, ed. Folate in Health and Disease. New York, NY: Marcel Dekker, Inc; 1995:23-42.
33. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297(21):2351-2359.
34. Food Standards Agency. Folic acid fortification. London, United Kingdom: Food Standards Agency; 2007. (http://www.food.gov.uk/healthiereating/ folicfortification/). (Accessed July 10, 2008).
35. Food Standards Agency. Update on folic acid fortification. London, United Kingdom: Food Standards Agency; 2008. (http://www.food.gov.uk/news/newsarchive/ 2008/mar/folic). (Accessed July 10, 2008).
36. Mills JL, Von Kohorn I, Conley MR, et al. Low vitamin B-12 concentrations in patients without anemia: the effect of folic acid fortification of grain. Am J Clin Nutr. 2003;77(6):1474-1477.
37. Kado DM, Karlamangla AS, Huang MH, et al. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med. 2005;118(2):161-167.
38. Mooijaart SP, Gussekloo J, Frölich M, et al. Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus Study. Am J Clin Nutr. 2005;82(4):866-871.
39. Nurk E, Refsum H, Tell GS, et al. Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study. Ann Neurol. 2005;58(6):847-857.
40. Ravaglia G, Forti P, Maioli F, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr. 2005;82(3):636-643.
41. Tucker KL, Qiao N, Scott T, et al. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr. 2005;82(3):627-635.
42. McMahon JA, Green TJ, Skeaff CM, et al. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med. 2006;354(26):2764-2772.
43. Durga J, van Boxtel MP, Schouten EG, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet. 2007;369(9557):208- 216.